The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: Implications for trials diabetes prevention in humans

Diabetes/Metabolism Research and Reviews

Volumn 20, Issue 5, 2004, Pages 394-398

  Valorani, M G ^a   Hawa, M I ^a   Buckley, L R ^a   Afeltra, A ^b   Cacciapaglia, F ^b   Pozzilli, P ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Insulin content; Lymphocytic infiltration; NOD mouse; Type 1 diabetes

Indexed keywords

INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DESTRUCTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; INSULITIS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; GLYCOSURIA; INSULIN; LONGITUDINAL STUDIES; MALE; MICE; MICE, INBRED NOD; PANCREAS;

EID: 4644316520     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.463     Document Type: Article

References (21)

1. Tochino Y. Discovery and breeding of the NOD mouse. In Insulitis and Type 1 Diabetes-lessons From the NOD Mouse, Tarui S, Tochino Y, Nonaka K (eds). Academic Press: Japan, 1986; 3-10.
2. Pozzilli P, Signore A, Williams AJK, Beales PE. NOD mouse colonies around the world - recent facts and figures. Immunol Today 1993; 14: 193-196.
3. Atkinson MA, Maclaren NK. Mechanism of disease: the pathogenesis of insulin dependent diabetes mellitus. New Engl J Med 1994; 331: 1428-1436.
4. Meagher C, Sharif S, Ilussain S, Cameron MJ, Arreanza GA, Delovitch TL. Cytokines and chemokines in the pathogenesis of murine type 1 diabetes. Adv Exp Med Biol 2003; 520: 133-158.
5. Signore A, Pozzilli P, Gale EA, Andreani D, Beverley PC. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 1989; 32: 282-289.
6. Pozzilli P. Prevention of insulin-dependent diabetes mellitus. Diabetes Metab Rev 1998; 14: 69-84.
7. Greenbaum CJ, Harrison LC. Guidelines for intervention trials in subjects with newly diagnosed Type 1 diabetes. Diabetes 2003; 52: 1059-1065.
8. Mansfield KJ, Beales PE, Williams AJK, Pozzilli P. The breeding housing and life-maintenance of the non-obese diabetic mouse. Animal Technol 1992; 43: 29-37.
9. N.I.H. Principles of laboratory animal care. Publication no. 83-25, revised 1985.
10. HMSO (Her Majesty's Stationary Office). Animals (Scientific Procedures) ACT, London, 1986.
11. Amrani A, Durant S, Throsby M, Coulaud J, Dardenne M, Homo-Delarche F. Glucose homeostasis in the nonobese diabetic mouse at the prediabetic stage. Endocrinology 1998; 139(11): 15-24.
12. Fourlanos S, Narendran P, Colman PG, Harrison LC. Fasting insulin, fasting glucose and insulin resistance is increased in pre-clinical Type 1 diabetes. Diabetologia 2003; 46(Suppl. 2): A14 (Abstract 35).
13. Signore A, Procaccini E, Toscano AM, et al. Histological study of pancreatic beta cell loss in relation to the insulitis process in the non-obese diabetic mouse. Histochemistry 1994; 101: 263-269.
14. Tasaka Y, Inoue Y, Marumo K, Mizuno Y, Hirata Y, Akao Y. Insulin, glucagon and somatostatin content of the non-obese diabetic (NOD) mouse pancreas and plasma virus antibodies to Coxsackie B- and reoviruses. Tohoku J Exp Med 1985; 146: 153-162.
15. Yamada S, Irie J, Shimada A, et al. Assessment of beta cell mass and oxidative peritoneal exudate cells in murine type 1 diabetes using adoptive transfer system. Autoimmunity 2003; 36: 63-70.
16. Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W, Polonsky KS. Increased β-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes 1999; 48: 989-996.
17. Gazda LS, Charlton B, Lafferty KJ. Diabetes results from a late change in the autoimmune response of NOD mice. J Autoimmunity 1997; 10: 261-270.
18. Shimada A, Charlton B, Taylor-Edwards C, Fathman CG. β-cell estruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 1996; 45: 1063-1067.
19. Bergerot I, Fabien N, Maguer V, Thivolet C. Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes. Clin Exp Immunol 1995; 102: 335-340.
20. Bache I, Jorgensen KH, Buschard K. Failure of high-dose insulin treatment to increase beta-cell insulin content in diabetic non obese diabetic (NOD) mice. Diabetes Res Clin Pract 1997; 37: 9-14.
21. Shapiro AM, Suarez-Pinzon WL, Power R, Rabinovich A. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice. Diabetologia 2002; 45: 224-230.